Latest News.

/Latest News.

Coronavirus: Instructions for amyloidosis patients

Vaccination is vital to help control COVID19 and keep you and the community well. If we in Australia with the rest of the world are going to control COVID 19 also known as the  Corona Virus  and we want the Australian state borders to remain open, it is [...]

2021-06-30T12:09:44+00:00December 7th, 2020|Latest News.|

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

Authors David Adams Yukio Ando João Melo Beirão Teresa Coelho Morie A. Gertz Julian D. Gillmore Philip N. Hawkins Isabelle Lousada Ole B. Suhr Giampaolo Merlini Abstract Amyloid transthyretin (ATTR) amyloidosis with polyneuropathy (PN) is a progressive, debilitating, systemic disease wherein transthyretin protein misfolds to form amyloid, which is deposited in the endoneurium. ATTR amyloidosis with PN is the most serious hereditary polyneuropathy [...]

2020-01-14T17:54:26+00:00January 14th, 2020|Latest News.|

2nd European meeting for ATTR amyloidosis

Reports from the 2nd European meeting for ATTR amyloidosis for doctors and patients from the NZ ATTR Amyloidosis Patients Association and the Australian ATTR Amyloidosis Alliance representative. This very successful fourday conference was held at the beginning of September in Berlin. Amongst the delegates were Jaime and Aubrey Christmas who [...]

2019-10-17T09:38:09+00:00October 17th, 2019|Latest News.|

2019 International Myeloma Workshop

The International Myeloma Workshop was held in Boston, USA from 12th-15th September 2019. This is a conference attended by >3000 medical professionals every 2 years, where world leaders in the treatment of myeloma and associated disease - such as systemic AL amyloidosis - present and discuss data regarding new [...]

2019-09-22T18:15:56+00:00September 22nd, 2019|Latest News.|